|
|
|
|
|
1. Report Overview 1.1 Why You Should Read This Report 1.2 How This Report Delivers 1.3 Key Questions Answered by This Analytical Report Include: 1.4 Who is This Report for? 1.5 Methodology 1.5.1 Primary Research 1.5.2 Secondary Research 1.5.3 Market Evaluation & Forecasting Methodology 1.6 Frequently Asked Questions (FAQ) 1.7 Associated Visiongain Reports 1.8 About Visiongain
2. Introduction to the Neurostimulation Devices Market 2.1 Classification of Neurostimulation Devices 2.2 What are Neurostimulation Devices? 2.3 Regulation of Medical Devices? 2.3.1 The US Approval and Regulation System 2.3.2 The EU Approval and Regulation System 2.3.3 China Approval and Regulation System 2.3.4 Japan Approval and Regulation System 2.3.5 India Approval and Regulation System
3. Neurostimulation Devices Market: Drivers & Restraints 3.1 Driving Factors 3.1.1 Growing prevalence of neurological disorders 3.1.2 Increasing Growth of Aging Population 3.1.3 Changing Lifestyle and growing obesity 3.1.4 Various opportunities from emerging markets 3.2 Market Restraints 3.2.1 Shortage of neurologists to treat an increasing number of neurologic patients 3.2.2 Uncertain outcomes of changing healthcare policies 3.2.3 Imposition of the medical device excise tax in the U.S. 3.2.4 Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries
4. Global Neurostimulation Devices Market by Product, 2019-2029 4.1 Spinal Cord Stimulators Market Forecast 2019-2029 4.2 Deep Brain Stimulators Market Forecast 2019-2029 4.3 Vagus Nerve Stimulators Market Forecast 2019-2029 4.4 Sacral Nerve Stimulators: Market Forecast 2019-2029 4.5 Cortical Stimulators Market Forecast 2019-2029 4.6 Other Neurostimulation Devices Market Forecast 2019-2029
5. Global Neurostimulation Devices Market by Application, 2019-2029 5.1 Epilepsy Neurostimulation Devices Market Forecast 2019-2029 5.2 Pain Management Neurostimulation Devices Market Forecast 2019-2029 5.3 Hearing Loss Neurostimulation Devices Market Forecast 2019-2029 5.4 Urinary and Faecal Incontinence Neurostimulation Devices Market Forecast 2019-2029 5.5 Gastroparesis Neurostimulation Devices Market Forecast 2019-2029 5.6 Parkinson¡¯s Disease Neurostimulation Devices Market Forecast 2019-2029 5.7 Others Application Market Forecast 2019-2029
6. Global Neurostimulation Devices Market by Region, 2019-2029 6.1 Introduction 6.2 Regional Breakdown of the Global Neurostimulation Devices Market 6.3 How will Regional Market Shares Change to 2029? 6.4 North America Neurostimulation Devices Market 2019-2029 6.4.1 U.S. Neurostimulation Devices Market Forecast 2019-2029 6.4.2 Canada Neurostimulation Devices Market Forecast 2019-2029 6.5 Europe Neurostimulation Devices Market Forecast 2019-2029 6.5.1 Germany Neurostimulation Devices Market Forecast 2019-2029 6.5.2 France Neurostimulation Devices Market Forecast 2019-2029 6.5.3 UK Neurostimulation Devices Market Forecast 2019-2029 6.5.4 Italy Neurostimulation Devices Market Forecast 2019-2029 6.5.5 Spain Neurostimulation Devices Market Forecast 2019-2029 6.5.6 Rest of Europe (RoE) 6.6 Asia-Pacific Neurostimulation Devices Market Forecast 2019-2029 6.6.1 Japan Neurostimulation Devices Market Forecast 2019-2029 6.6.2 China Neurostimulation Devices Market Forecast 2019-2029 6.6.3 India Neurostimulation Devices Market Forecast 2019-2029 6.6.4 Rest of Asia-pacific Neurostimulation Devices Market Forecast 2019-2029 6.7 Rest of the World Neurostimulation Devices Market Forecast 2019-2029 6.7.1 Latin America Neurostimulation Devices Market Forecast 2019-2029 6.7.2 Middle East & Africa Neurostimulation Devices Market Forecast 2019-2029
7. Leading Companies in the Neurostimulation Devices Market 7.1 Advanced Bionics, LLC 7.1.1 Advanced Bionics, LLC: Overview 7.1.2 Advanced Bionics, LLC: Financials 7.1.3 Advanced Biologics, LLC: Product Portfolio 7.1.4 Advanced Biologics, LLC: Developments 7.2 Boston Scientific Corporation 7.2.1 Boston Scientific: Overview 7.2.2 Boston Scientific: Financials 7.2.3 Boston Scientific: Product portfolio 7.2.4 Boston Scientific: Developments 7.3 Cochlear Ltd. 7.3.1 Cochlear Ltd.: Overview 7.3.2 Cochlear Ltd.: Financials 7.3.3 Cochlear Ltd.: Product Portfolio 7.3.4 Cochlear Ltd.: Developments 7.4 Cyberonics 7.4.1 Cyberonics: Overview 7.4.2 Cyberonics: Financials 7.4.3 Cyberonics: Products Portfolio 7.4.4 Cyberonics: Developments 7.5 Medtronic plc 7.5.1 Medtronic plc: Overview 7.5.2 Medtronic plc: Financials 7.5.3 Medtronic plc: Product Portfolio 7.5.4 Medtronic plc: Developments 7.6 Neuronetics, Inc. 7.6.1 Neuronetics, Inc: Overview 7.6.2 Neuronetics, Inc: Financials 7.6.3 Neuronetics, Inc: Product Portfolio 7.6.4 Developments 7.7 Nevro Corp. 7.7.1 Nevro Corp.: Overview 7.7.2 Nevro Corp.: Financials 7.7.3 Nevro Corp.: Product Portfolio 7.7.4 Nevro Corp.: Developments 7.8 Cogentix Medical Inc 7.8.1 Cogentix Medical Inc: Overview 7.8.2 Cogentix Medical Inc: Financials 7.8.3 Cogentix Medical Inc: Product Portfolio 7.8.4 Cogentix Medical Inc: Developments 7.9 St. Jude Medical 7.9.1 St. Jude Medical: Overview 7.9.2 St. Jude Medical: Financials 7.9.3 St. Jude Medical: Product Portfolio 7.9.4 St. Jude Medical: Developments 7.10 NDI Medical, LLC. 7.10.1 NDI Medical, LLC.: Overview 7.10.2 NDI Medical, LLC.: Product portfolio 7.10.3 NDI Medical, LLC.: Developments
8. The Global Neurostimulation Devices Market, Competitive Landscape 8.1 New Product Launches 8.2 Acquisitions, Collaborations, and Partnerships 8.3 Other Developments
9. Conclusions 9.1 Top Neurostimulation Devices Market 9.2 Top Neurostimulation Devices Applications Market 9.3 Top Nations Neurostimulation in the Devices Market
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form
List of Tables Table 4.1 Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.3 Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.4 Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.6 Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 4.7 Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.1 Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.6 Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.7 Parkinson¡¯s Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.1 Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.2 North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.3 North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.4 North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.5 Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.6 Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.7 Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.8 Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.9 Asia-Pacific Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.10 Asia-Pacific Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.11 Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.12 Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 6.13 Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029 Table 7.1 Advanced Bionics Product Portfolio Table 7.2 Advanced Bionics: Developments Table 7.3 Boston Scientific Corporation: Product Portfolio Table 7.4 Boston Scientific Corporation: Developments Table 7.5 Cochlear Ltd.: Product Portfolio Table 7.6 Cochlear Ltd.: Developments Table 7.7 Cyberonics.: Product Portfolio Table 7.8 Cyberonics: Developments Table 7.9 Medtronic plc: Product Portfolio Table 7.10 Medtronic plc: Developments Table 7.11 Neuronetics: Product Portfolio Table 7.12 Neuronetics: Developments Table 7.13 Nevro Corp: Product Portfolio Table 7.14 Nevro Corp: Developments Table 7.15 Cogentix Medical: Product Portfolio Table 7.16 Cogentix Medical: Developments Table 7.17 St. Jude Medical: Product Portfolio Table 7.18 St. Jude Medical: Developments Table 7.19 NDI Medical: Product Portfolio Table 7.20 NDI Medical: Developments Table 8.1 New Product Launches Table 8.2 Acquisitions, Collaborations, and Partnerships Table 8.3 Other Developments
List of Figures Figure 2.1 Neurostimulation Devices Market Segmentation Figure 2.2 Stages of regulatory control Figure 3.1 Neurostimulation Devices Market: Drivers and Restraints, 2019-2029 Figure 3.2 Share of geriatric population, by region, 2010-2020 Figure 4.1 Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 4.3 Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 4.4 Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2019-2029 Figure 4.6 Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 4.7 Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.1 Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.6 Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.7 Parkinson¡¯s Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029 Figure 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m), 2019-2029 Figure 6.1 Neurostimulation Devices Markets by Region: Share (%), 2018 Figure 6.2 North America Neurostimulation Devices Markets by Country: Share (%), 2018 Figure 6.3 U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.4 Increasing Prevalence Rate in Canada by Chronic Diseases, 2001-2039 Figure 6.5 Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.6 Europe Neurostimulation Devices Markets by Country: Share (%), 2018 Figure 6.7 Change in population structure in Germany, 1995-2015 Figure 6.8 Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.9 France Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.10 U.K. Population estimates and projections, 2010-2039 Figure 6.11 U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.12 Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.13 Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.14 Asia-Pacific Neurostimulation Devices Markets by Country (%), 2018 Figure 6.15 Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.16 Share of Aging population in total Chinese population, 2011-2016 (%) Figure 6.17 China Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.18 India Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.19 Rest of the World Neurostimulation Devices Markets by Region (%), 2018 Figure 6.20 Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 6.21 Middle East and Africa Revenue Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029 Figure 7.1 Advanced Bionics: Historical Revenues ($m), 2015-2017 Figure 7.2 Boston Scientific Corporation: Historical Revenues ($m), 2015-2017 Figure 7.3 Cochlear: Historical Revenues ($m), 2015-2017 Figure 7.4 Cyberonics: Historical Revenues ($m), 2015-2017 Figure 7.5 Medtronic plc: Recent Financials, 2015-2017 Figure 7.6 Nevro Corp: Recent Financials, 2015-2017 Figure 7.7 Cogentix Medical, Inc.: Recent Financials, 2016-2017 Figure 7.8 St. Jude Medical: Recent Financials, 2015-2017 Figure 9.1 Top Neurostimulation Devices Market Figure 9.2 Top Neurostimulation Devices Applications Figure 9.3 Top Nations in the Neurostimulation Devices Market Title: Global Neurostimulation Devices Market 2019-2029
Report Scope
• Global Neurostimulation Devices Market from 2019-2029
• Forecast of the Global Neurostimulation Devices market by Product: • Spinal Cord Stimulators • Deep Brain Stimulators • Sacral Nerve Stimulators • Vagus Nerve Stimulators • Cortical Stimulators • Others
Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa
• Forecast of the Global Neurostimulation Devices market by Application: • Pain Management • Epilepsy • Urinary and Fecal Incontinence • Hearing Loss • Gastroparesis • Parkinson¡¯s Disease • Others
Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • North America: US, Canada • Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe • Asia-Pacific: Japan, China, India and rest of Asia-Pacific • RoW: Latin America, Middle East & Africa
• Our study discusses the selected leading companies that are the major players in the neurostimulation devices market: • Advanced Bionics • Boston Scientific Corporation • Cochlear ltd • Cyberonics • Medtronic • Neuronetics Inc • Nervo Corp. • Cogentic Medical Inc • St Jude Medical • NDI Medical |
|
|
|
|
|
|
ÁÖÀÇ:
·Î±×ÀÎ ÈÄ ¹Ù±¸´Ï¿¡ ´ã°Å³ª ±¸¸ÅÇØ ÁÖ¼¼¿ä.
|
|
|
|
|
|
|
ÈÆó |
ȯÀ² (ÇϳªÀºÇà ¼Û±Ýº¸³¾¶§) |
¹Ì±¹USD |
\ 1,397.60 |
ÀϺ»JPY |
\ 9.0396 |
À¯·ÎEUR |
\ 1,487.19 |
¿µ±¹GBP |
\ 1,737.29 |
|
|
|
|
|